Which hedge funds own BCAX? BICARA THERAPEUTICS INC, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in BCAX (BICARA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $251.2m in total. The largest holder by portfolio weight is RA Capital Management at 1.9% of its book.
5tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold BCAX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 1.9% | $215.4m | 7,255,993 | 0% | held |
| Woodline Partners | Q2 2026 | 0.0% | $6.9m | 232,690 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $14.8m | 498,193 | 80% | added |
| Millennium Management | Q2 2026 | 0.0% | $7.8m | 262,254 | 67% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $6.3m | 211,142 | -87% | reduced |
How has hedge fund ownership of BCAX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $251.2m |
| Q1 2026 | 5 | $190.6m |
| Q4 2025 | 3 | $121.4m |
| Q3 2025 | 4 | $116.1m |
| Q2 2025 | 3 | $69.9m |
| Q1 2025 | 2 | $95.2m |
| Q4 2024 | 2 | $126.0m |
| Q3 2024 | 4 | $194.2m |
Counts every tracked manager that disclosed BCAX in that quarter's filing, including managers that have since stopped filing.